Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Neuroimaging markers associated with maintenance of optimal memory performance in late-life.

Dekhtyar M, Papp KV, Buckley R, Jacobs HIL, Schultz AP, Johnson KA, Sperling RA, Rentz DM.

Neuropsychologia. 2017 Jun;100:164-170. doi: 10.1016/j.neuropsychologia.2017.04.037. Epub 2017 May 1.

PMID:
28472627
2.

Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.

Vannini P, Amariglio R, Hanseeuw B, Johnson KA, McLaren DG, Chhatwal J, Pascual-Leone A, Rentz D, Sperling RA.

Neuropsychologia. 2017 May;99:343-349. doi: 10.1016/j.neuropsychologia.2017.04.002. Epub 2017 Apr 3.

PMID:
28385579
3.

Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.

Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, Maruff P.

Alzheimers Dement (Amst). 2016 Oct 18;6:108-121. doi: 10.1016/j.dadm.2016.09.002. eCollection 2017. Review.

4.

Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.

Franzmeier N, Duering M, Weiner M, Dichgans M, Ewers M; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2017 Mar 14;88(11):1054-1061. doi: 10.1212/WNL.0000000000003711. Epub 2017 Feb 10.

PMID:
28188306
5.

Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults.

Hammers DB, Atkinson TJ, Dalley BC, Suhrie KR, Beardmore BE, Burrell LD, Horn KP, Rasmussen KM, Foster NL, Duff K, Hoffman JM.

Clin Neuropsychol. 2017 Apr;31(3):531-543. doi: 10.1080/13854046.2016.1278039. Epub 2017 Jan 12.

PMID:
28077020
6.

In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.

Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA.

Neuroimage. 2017 Mar 1;148:296-304. doi: 10.1016/j.neuroimage.2016.12.026. Epub 2016 Dec 15.

PMID:
27989773
7.

Amyloid deposition in younger adults is linked to episodic memory performance.

Bischof GN, Rodrigue KM, Kennedy KM, Devous MD Sr, Park DC.

Neurology. 2016 Dec 13;87(24):2562-2566. Epub 2016 Nov 11.

PMID:
27837001
8.

Asymptomatic Alzheimer disease: Defining resilience.

Hohman TJ, McLaren DG, Mormino EC, Gifford KA, Libon DJ, Jefferson AL; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Dec 6;87(23):2443-2450. Epub 2016 Nov 4.

PMID:
27815399
9.

Genetic resilience to amyloid related cognitive decline.

Hohman TJ, Dumitrescu L, Cox NJ, Jefferson AL; Alzheimer’s Neuroimaging Initiative.

Brain Imaging Behav. 2017 Apr;11(2):401-409. doi: 10.1007/s11682-016-9615-5.

PMID:
27743375
10.

Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance.

Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KA.

Brain Imaging Behav. 2017 Apr;11(2):383-390. doi: 10.1007/s11682-016-9640-4.

11.

The influence of demographic factors on subjective cognitive concerns and beta-amyloid.

Aghjayan SL, Buckley RF, Vannini P, Rentz DM, Jackson JD, Sperling RA, Johnson KA, Amariglio RE.

Int Psychogeriatr. 2017 Apr;29(4):645-652. doi: 10.1017/S1041610216001502. Epub 2016 Oct 11.

12.

APP Overexpression Causes Aβ-Independent Neuronal Death through Intrinsic Apoptosis Pathway.

Cheng N, Jiao S, Gumaste A, Bai L, Belluscio L.

eNeuro. 2016 Aug 1;3(4). pii: ENEURO.0150-16.2016. doi: 10.1523/ENEURO.0150-16.2016. eCollection 2016 Jul-Aug.

13.

Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.

Wei Z, Chen XC, Song Y, Pan XD, Dai XM, Zhang J, Cui XL, Wu XL, Zhu YG.

Chin Med J (Engl). 2016 Aug 5;129(15):1835-44. doi: 10.4103/0366-6999.186646.

14.

Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging.

Vemuri P, Fields J, Peter J, Klöppel S.

Curr Opin Neurol. 2016 Aug;29(4):405-11. doi: 10.1097/WCO.0000000000000346. Review.

15.

A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.

Loewenstein DA, Curiel RE, Greig MT, Bauer RM, Rosado M, Bowers D, Wicklund M, Crocco E, Pontecorvo M, Joshi AD, Rodriguez R, Barker WW, Hidalgo J, Duara R.

Am J Geriatr Psychiatry. 2016 Oct;24(10):804-13. doi: 10.1016/j.jagp.2016.02.056. Epub 2016 Apr 4.

PMID:
27160985
16.

Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.

Maye JE, Betensky RA, Gidicsin CM, Locascio J, Becker JA, Pepin L, Carmasin J, Rentz DM, Marshall GA, Blacker D, Sperling RA, Johnson KA.

Neurobiol Aging. 2016 Apr;40:61-7. doi: 10.1016/j.neurobiolaging.2015.12.013. Epub 2015 Dec 28.

17.

Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.

Clark LR, Racine AM, Koscik RL, Okonkwo OC, Engelman CD, Carlsson CM, Asthana S, Bendlin BB, Chappell R, Nicholas CR, Rowley HA, Oh JM, Hermann BP, Sager MA, Christian BT, Johnson SC.

Alzheimers Dement. 2016 Jul;12(7):805-14. doi: 10.1016/j.jalz.2015.12.009. Epub 2016 Jan 21.

18.

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.

Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, McDade E, Aizenstein HJ, Klunk WE, Mathis CA.

Neuroimage Clin. 2015 Oct 14;9:592-8. doi: 10.1016/j.nicl.2015.10.007. eCollection 2015.

19.

Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.

Malishkevich A, Marshall GA, Schultz AP, Sperling RA, Aharon-Peretz J, Gozes I.

J Alzheimers Dis. 2016;50(1):249-60. doi: 10.3233/JAD-150799.

20.

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.

Liu-Seifert H, Siemers E, Price K, Han B, Selzler KJ, Henley D, Sundell K, Aisen P, Cummings J, Raskin J, Mohs R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(1):205-14. doi: 10.3233/JAD-142508.

Supplemental Content

Support Center